Summer internship - 2017 HR Anexi

1
A REPORT ON
“ A study in the area of Recruitment and Selection in Health Care Sector ”
Conducted At
HR ANEXI PVT LTD
Submitted by
Rahul Chatterjee
Registration no. - 16MB0897
Under the guidance of
Prof. Preeja Sridhar
In partial fulfillment of the requirements for the
Award of the degree of
MASTER OF BUSINESS ADMINISTRATION 2017
Submitted to

2
INTERNATIONAL SCHOOL OF BUSINESS AND RESEARCH,
BANGALORE, INDIA
2016-18
CERTIFICATE
This is to certify that Mr. Rahul Chatterjee , Roll no. 16MB0897, student of
MBA has successfully completed his project on “ A study in the area of
Recruitment in Health Care Sector ” in partial fulfillment for the award of
degree of MBA during which the academic session 2016-18. The project report
has been approved as it satisfies the academic requirements prescribed for the
said degree.
Prof. Preeja Sridhar Dr. T. Karpagam
Guide Director Academics
Dated:
Examiner:

3
Declaration
I , Rahul Chatterjee , Roll no 16MB0897, student of MBA of ISBR
Business School, Bangalore hereby declare that the research project report on
“Human Resource Management” is an original and authenticated work done
by me. I further declare that it has not been submitted elsewhere by any other
person in any of the university for the Award of any degree or diploma.
Date: Rahul Chatterjee

4
ACKNOWLEDGEMENT
The success of any project is the result of hard work & endeavour of not one but
many people and this project is no different. It would not have been possible
without the kind support and help of many individuals and organisations. I
would like to extend my sincere thanks to all of them.
Firstly, I express my deep sense of gratitude to Mr. Unni Krishnan, vice
president HR Anexi for his endeavor approach and outstanding supervision by
which it has been possible for me to make a good combination of theoretical
and practical knowledge in preparing this report.
I sincerely thank Mrs. Preeja Sridhar for her guidance and encouragement in
carrying out this project work. I also wish to express my gratitude to the
officials and other staff members of HR Anexi who rendered their help during
the period of my project work.
Most of all, I am fully indebted to Mr. Arni Arnab who have been my mentors ,
for his understanding, wisdom, patience, enthusiasm and encouragement and for
pushing me farther than I thought I could go.
I specially thank the Director of International School of Business and Research
Dr. Karpagam who was my mentor during 1st
semester and had motivated me
alot , also for providing me the opportunity to embark on this project .

5
CONTENTS
Executive summary…………………………………………..………6
Chapter I : INTRODUCTION…..………..……………………………...7
1. Company profile………………………………….......………..…8
2. Mission……………………………….……………………………8
3. Vision…………………………………………………..……….…9
4. Values……………………………………………….………….…9
5. Partners…………………………………………………………..10
6. Various verticals of the company………....................………….10
Chapter II: LITERATURE REVIEW………………………………...11
1. History of Health care industry…………………………………12
2. Pharmaceutical industry…………………………………………16
3. Biotechnological industry……………………………………...…18
4. Relation between Pharma and Biotech industry………………..22
5. Objectives of the study……………………………………………24
6. Internship Activities …………………………..........………….....24
7. Research methodology…………………………..........…………..25
8. Research design…………………………………….....…………..27
Chapter III……………………………………………………………32
1. Questionnaire Design……………………………………………..33
2. Analysis and interpretation………………….............………..….33
Chapter IV…………………………………………………………….34
Assessment of the Internship……………………………..……35
Chapter V……………………………………………………….……..36
1. Conclusion…………………………………………………………37
2. Limitations of the study………………………….........…………..37
Appendix……………………………………………………………….38
1. Bibliography………………………………………………………38
2. Questionnaire……………………………………………………..39

6
3. CIT…………………………………………………………………40
EXECUTIVE SUMMARY
HR Anexi is a strategic human capital consulting organization with a complete
array of capabilities in talent assessment, organization development, employee
engagement, HR outsourcing, research and survey. It was established in 2007
by industry professionals from rich and diverse business backgrounds. HR
Anexi has extensive experience in helping organizations attract, build and retain
their top talent. It is head quartered in Mumbai. Mr. Ashish is the founder and
Managing Director of HR Anexi.
At HR Anexi, they believe people are not just the biggest asset for any
organization, they are very asset creators! Every activity they undertake or
recommend to their clients is underpinned with their resolve of “Powering
Organizations, Empowering People.”
The banking system in India has undoubtedly earned numerous outstanding
achievements, in a comparatively short time, for the World’s largest and the
most diverse democracy. There have been several reforms in the Indian banking
sector, as well as quite a few successful mergers and acquisitions, which have
helped it, grow manifold. These mergers will automatically affects human
resources in the banks.
I designed and undertook a research to understand the opportunities and
challenges for human resources management during bank mergers and how
these effects the organisation as a whole.

8
COMPANY PROFILE
HR Anexi is a strategic human capital consulting organization with a complete
array of capabilities in talent assessment, organization development, employee
engagement, HR outsourcing, research and survey. Established in 2007 by
industry professionals from rich and diverse business backgrounds, HR Anexi
has extensive experience in helping organizations attract, build and retain their
top talent. It is head quartered in Mumbai. Mr. Ashish is the founder and
Managing Director of HR Anexi.
At HR Anexi, they believe people are not just the biggest asset for any
organization, they are very asset creators! Every activity they undertake or
recommend to their clients is underpinned with their resolve of “Powering
Organizations, Empowering People.”
MISSION:
HR Anexi’s mission lies in ‘Powering Organizations, Empowering People.’ We
help organizations transform their people from being Assets to Asset Creators.
Their purpose is to:
• Build organizations that attract, develop, excite and retain outstanding
talent
• Help businesses reach higher levels of profitability, quality and
productivity by leveraging their human capital.
VISION:
HR Anexi’s vision is to be an industry leader in organization development and
human resource management solutions for global and family run businesses.

9
They focus on:
• Provide best-in-class research based capabilities in leadership
development
• Deliver business focused human resource management (HRM) solutions
to family run businesses.
VALUES:
4P Values
At the core of their consulting approach and capabilities lie 4 simple yet
powerful values- they shape our solutions, guide our engagements, and drive
our service delivery.
1. Partnership:
They work with their clients as a single collaborative partner ensuring
continuity success in their business. They believe in delivering the best
possible solution, going beyond the call of human resource consulting, to
ensure ROI for their clients
2. Professionalism:
They are committed to high levels of quality, integrity, honesty &
transparency in all that they do. They strive for excellence in knowing
what, how and when to do it and doing it all the time.
3. Passion:
They are passionate about what we do and drive continuous re-
engineering & limitless improvement in everything they do. They believe
in “do what you love & you haven’t worked a single day in your life!”
4. People:
People are their pride and they are committed to their continuous growth
and development.
They respect individual uniqueness and focus on harnessing every drop to
form the mighty ocean.

10
Partners:
HR Anexi offers a rich, comprehensive suite of consulting capabilities in
strategic human capital management to its clients. They have strong alliances
with global human capital consulting houses that enable them to meet all of
their clients’ strategic, operational and tactical needs. Their partnerships result
in powerful synergies that help them to create a complete network of services in
leadership development, employee engagement and talent assessment for their
client organizations.
Blessing White (a division of GP Strategies)is a global human capital consulting
firm dedicated to creating sustainable high-performance organizations.
Established in 1973, they provide strategic consulting solutions in executive and
senior leader development, management capability building and employee
engagement.
Blessing White’s background research in leadership and the meaning of work
informs HR Anexi’s capabilities in Organization Development, Assessment, HR
Advisory and Outsourcing, and Research and Survey. Their partnership with
Blessing White enables them to provide business driven consulting to numerous
clients in multiple industries.

11
Established in 1984, Psytech is one of the world’s leading developers of
psychometric tests and assessment solutions for the workplace. With worldwide
representation and assessment products in multiple languages, they are
the ‘Global Leaders in Local Assessment Solutions.’
Their partnership with Psytech enables them to provide one of the world’s most
extensively researched, reliable and valid batteries of psychometric tools to their
clients. They use Psytech products as standalone solutions in assessment, 360-
degree feedback, and executive coaching, or integrate them into their larger
programs in talent development.
VARIOUS VERTICALS:
The various verticals of HR Anexi are:
HR Advisory and Outsourcing
• Organization Diagnostics
• Organization Structure
• Performance Management
• Compensation and Benefits
• Manpower Audit and Rightsizing
• Culture and Change Management
• HR Outsourcing
• Recruitment Process Outsourcing
Assessment
• Personality
• Values and Motivation
• General Aptitude
• Assessment Centers
• Development Centers
• 360-degree Feedback
• Competency Based Interviewing (CBI)
• Assessment Certifications

12
Organization Development
• Executive Leadership Development
• Leadership Development
• Management Development
• Competency Building Programs
• The Engagement Equation
• Managing Personal Growth
• Belief Changing Workshops – Small Change Big Difference
Research and Survey
• Compensation and Benefit Survey
• Employee Engagement Survey
• High-Performance Culture Scan
• Training Needs Identification (TNI)
• HR Audit
CHAPTER II
LITERATURE REVIEW

14
History Of Health Care Sector
The healthcare industry (also called the medical industry or health economy) is an
aggregation and integration of sectors within the economic system that provides goods and
services to treat patients with curative, preventive, rehabilitative, and palliative care. It
includes the generation and commercialization of goods and services lending themselves to
maintaining and re-establishing health.The modern healthcare industry is divided into many
sectors and depends on interdisciplinary teams of trained professionals
and paraprofessionals to meet health needs of individuals and populations.
The healthcare industry is one of the world's largest and fastest-growing industries.
Consuming over 10 percent of gross domestic product (GDP) of most developed nations,
health care can form an enormous part of a country's economy.
Healthcare Industry in India
• Healthcare has become one of India's largest sectors both in terms of revenue &
employment. The industry is growing at a tremendous pace owing to its strengthening
coverage, services and increasing expenditure by public as well private players
• During 2008-20, the market is expected to record a CAGR of 16.5 per cent
• The total industry size is expected to touch USD160 billion by 2017 & USD280
billion by 2020
• As per the Ministry of Health, development of 50 technologies has been targeted in
the FY16, for the treatment of diseases like Cancer & TB
• Government is emphasising on the eHealth initiatives such as Mother & Child
Tracking System (MCTS) & Facilitation Centre (MCTFC)
• Indian companies are entering into merger & acquisitions with domestic & foreign
companies to drive growth & gain new markets.

15
Backgrounds
For purpose of finance and management, the healthcare industry is typically divided into
several areas. As a basic framework for defining the sector, the United Nations International
Standard Industrial Classification (ISIC) categorizes the healthcare industry as generally
consisting of:
⚫ Hospital activities;
⚫ Medical and dental practice activities;
⚫ " Other human health activities ".
This third class involves activities of, or under the supervision of, nurses, midwives,
physiotherapists, scientific or diagnostic laboratories, pathology clinics, residential health
facilities, or other allied health professions, e.g. in the field of optometry, hydrotherapy,
medical massage, yoga therapy, music therapy, occupational therapy, speech therapy,
chiropody, homeopathy, chiropractics, acupuncture, etc.
The Global Industry Classification Standard and the Industry Classification
Benchmark further distinguish the industry as two main groups:
healthcare equipment and services; and
pharmaceuticals, biotechnology and related life sciences.
The healthcare equipment and services group consists of companies and entities that provide
medical equipment, medical supplies, and healthcare services, such as hospitals, home
healthcare providers, and nursing homes. The latter listed industry group includes companies
that produce biotechnology, pharmaceuticals, and miscellaneous scientific services.
Other approaches to defining the scope of the healthcare industry tend to adopt a broader
definition, also including other key actions related to health, such as education and training of
health professionals, regulation and management of health services delivery, provision
of traditional and complementary medicines, and administration of health insurance.
Providers and professionals: Healthcare provider and Health workforce
A healthcare provider is an institution (such as a hospital or clinic) or person (such as a
physician, nurse, allied health professional or community health worker) that provides
preventive, curative, promotional, rehabilitative or palliative care services in a systematic
way to individuals, families or communities.

16
The World Health Organization estimates there are 9.2 million physicians, 19.4 million
nurses and midwives, 1.9 million dentists and other dentistry personnel, 2.6 million
pharmacists and other pharmaceutical personnel, and over 1.3 million community health
workers worldwide, making the health care industry one of the largest segments of the
workforce.
The medical industry is also supported by many professions that do not directly provide
health care itself, but are part of the management and support of the health care system. The
incomes of managers and administrators, underwriters and medical malpractice attorneys,
marketers, investors and shareholders of for-profit services, all are attributable to health care
costs.
Delivery of services : Health care delivery
The delivery of healthcare services from primary care to secondary and tertiary levels of care
is the most visible part of any healthcare system, both to users and the general public. There
are many ways of providing healthcare in the modern world. The place of delivery may be in
the home, the community, the workplace, or in health facilities. The most common way is
face-to-face delivery, where care provider and patient see each other 'in the flesh'. This is
what occurs in general medicine in most countries. However, with modern
telecommunications technology, in absentia health care is becoming more common. This
could be when practitioner and patient communicate over the phone, video conferencing, the
internet, email, text messages, or any other form of non-face-to-face communication.
Improving access, coverage and quality of health services depends on the ways services are
organized and managed, and on the incentives influencing providers and users. In market-
based health care systems, for example such as that in the United States, such services are
usually paid for by the patient or through the patient's health insurance company. Other
mechanisms include government-financed systems (such as the National Health Service in
the United Kingdom). In many poorer countries, development aid, as well as funding through
charities or volunteers, help support the delivery and financing of health care services among
large segments of the population.
The structure of healthcare charges can also vary dramatically among countries. For instance,
Chinese hospital charges tend toward 50% for drugs, another major percentage for
equipment, and a small percentage for healthcare professional fees. China has implemented a
long-term transformation of its healthcare industry, beginning in the 1980s. Over the first
twenty-five years of this transformation, government contributions to healthcare expenditures
have dropped from 36% to 15%, with the burden of managing this decrease falling largely on
patients. Also over this period, a small proportion of state-owned hospitals have been
privatized. As an incentive to privatization, foreign investment in hospitals—up to 70%
ownership has been encouraged.

18
Pharmaceutical industry
The pharmaceutical industry discovers, develops, produces, and markets drugs or
pharmaceutical drugs for use as medications. Pharmaceutical companies may deal in generic
or brand medications and medical devices. They are subject to a variety of laws and
regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.
Pharmaceutical industry in India
◆ The pharmaceutical industry in India ranks 3rd in the world terms of volume and 14th in
terms of value. According to Department of Pharmaceuticals, Ministry of Chemicals and
Fertilizers, the total turnover of India's pharmaceuticals industry between 2008 and
September 2009 was US$21.04 billion. Hyderabad, Mumbai, Bangalore
, Visakhapatnam and Ahmedabad are the major pharmaceutical hubs of India. The
domestic market was worth US$13.8 billion in 2013.
◆ The government started to encourage the growth of drug manufacturing by Indian
companies in the early 1960s, and with the Patents Act in 1970. However, economic
liberalization in 90s by the former Prime Minister P.V. Narasimha Rao and the
then Finance Minister, Dr. Manmohan Singh enabled the industry to become what it is
today. This patent act removed composition patents from food and drugs, and though it
kept process patents, these were shortened to a period of five to seven years.
◆ The Lack of patent protection made the Indian market undesirable to the multinational
companies that had dominated the market. Whilst the multinationals streamed out, Indian
companies carved a niche in both the Indian and world markets with their expertise in
reverse-engineering new processes for manufacturing drugs at low costs. Although some
of the larger companies have taken baby steps towards drug innovation, the industry as a
whole has been following this business model until the present.
◆ India's biopharmaceutical industry clocked a 17 percent growth with revenues of Rs.137
billion ($3 billion) in the 2009-10 financial year over the previous fiscal. Bio-pharma
was the biggest contributor generating 60 percent of the industry's growth at Rs.8,829
crore, followed by bio-services at Rs.2,639 crore and bio-agri at Rs.1,936 crore.

20
Overview
⚫ The number of purely Indian big pharma companies is fairly low. Indian pharma industry
is mainly operated as well as controlled by dominant foreign companies having
subsidiaries in India due to availability of cheap labor in India at low cost. In 2002, over
20,000 registered drug manufacturers in India sold $9 billion worth of formulations and
bulk drugs. 85% of these formulations were sold in India while over 60% of the bulk
drugs were exported, mostly to the United States and Russia. Most of the players in the
market are small-to-medium enterprises; 250 of the largest companies control 70% of
the Indian market. Thanks to the 1970 Patent Act, multinationals represent only 35%
of the market, down from 70% thirty years ago.
⚫ Most pharma companies operating in India, even the multinationals, employ Indians
almost exclusively from the lowest ranks to high level management.[citation
needed] Homegrown pharmaceuticals, like many other businesses in India, are often a
mix of public and private enterprise.
⚫ In terms of the global market, India currently holds a modest 1–2% share, but it has
been growing at approximately 10% per year. India gained its foothold on the global
scene with its innovatively engineered generic drugs and active pharmaceutical
ingredients (API), and it is now seeking to become a major player in outsourced clinical
research as well as contract manufacturing and research. There are 74 US FDA-
approved manufacturing facilities in India, more than in any other country outside the
U.S, and in 2005, almost 20% of all Abbreviated New Drug Applications (ANDA) to the
FDA are expected to be filed by Indian companies. Growth in other fields
notwithstanding, generics are still a large part of the picture. London research company
Global Insight estimates that India’s share of the global generics market will have risen
from 4% to 33% by 2007. The Indian pharmaceutical industry has become the third
largest producer in the world and is poised to grow into an industry of $20 billion in
2015 from the current turnover of $12 billion.

21
Biotechnological Industry
⚫ The American Chemical Society defines biotechnology as the application of
biological organisms, systems, or processes by various industries to learning
about the science of life and the improvement of the value of materials and
organisms such as pharmaceuticals, crops, and livestock.
⚫ The biotechnology sector of India is highly innovative and is on a strong growth
trajectory. The sector, with its immense growth potential, will continue to play a
significant role as an innovative manufacturing hub. The sector is one of the most
significant sectors in enhancing India's global profile as well as contributing to the
growth of the economy.
⚫ India is among the top 12 biotech destinations in the world and ranks third in the Asia-
Pacific region. India has the second-highest number of US Food and Drug
Administration (USFDA)–approved plants, after the USA and is the largest producer of
recombinant Hepatitis B vaccine. Out of the top 10 biotech companies in India (by
revenue), seven have expertise in bio-pharmaceuticals and three specialise in agri-
biotech.
⚫ India has no dearth of talent in biotechnology, as a number of institutions, both
government and autonomous, provide the necessary opportunities for the students
seeking to obtain a degree in this sector. The Government of India has provided adequate
scope to this sector by providing facilities for Research and Development (R&D) in the
field of biotechnology.
Biotechnology industry in India : Robust growth in Biotech industry
• Growing at a faster pace, in comparison with the previous years, the Indian biotech
industry witnessed YoY growth of 57.14 per cent in FY16; the total industry size stood at
US$ 11 billionby FY16 and is estimated to reach US$ 11.6 billion by FY17
• Fast-paced growth is likely to continue; the industry is expected to increase in size to
US$ 11.6 billion by 2017, driven by a range of factors such as growing demand, intensive
R&D activities and strong government initiatives .

22
Market size
The Indian biotech industry holds about 2 per cent share of the global biotech industry. The
biotechnology industry in India, comprising about 800 companies, is expected to be valued
at US$ 11.6 billion in 2017. The government has to invest US$ 5 billion to develop human
capital, infrastructure and research initiatives if it is to realise the dream of growing the sector
into a US$ 100 billion industry by 2025, as per Union Minister for Science and Technology,
Mr Harsh Vardhan.
Biopharma is the largest sector contributing about 62 per cent of the total revenue followed
by bio-services (18 per cent), bio-agri (15 per cent), bio-industry (4 per cent), and bio-
informatics contributing (1 per cent).
The high demand for different biotech products has also opened up scope for the foreign
companies to set up base in India.
India has emerged as a leading destination for clinical trials, contract research and
manufacturing activities owing to the growth in the bio-services sector.
Investments
India's biotech sector has attracted significant amount of attention over the past two
decades. Several global companies have aggressively joined hands with Indian companies
due to India's strong generic biotechnology potential. Some of the recent investments and
developments in this sector are as follows:
• The Telangana state government's flagship pharma and biotech event - BioAsia
2017 attracted investments to the tune of Rs 3,382 crore (US$ 507.3 million).
• During the Vibrant Gujarat Global Summit-2017, 54 MoUs worth Rs 5,022 crore (US$
736.1 million) in the biotechnology sector were signed by 37 companies.
• Syngene International Ltd, the contract research services arm of Biocon Ltd, is
setting up a drug discovery and development center in Bengaluru for Amgen Inc., a
biotechnology company based in the US.

24
Government Initiatives
A Network of Technology Centre and promotion of start-ups by Small Industries
Development Bank of India (SIDBI) are among the steps taken by the Government of India
to promote innovation and entrepreneurship in the agro industry proposed by the Ministry of
Micro, Small & Medium Enterprises (MSME) in a new scheme. The Government of India has
taken several initiatives to improve the biotechnology sector in the country as well as offer
enough scope for research in this field. The Department of Biotechnology (DBT) along with
other government funded institutions such as National Biotechnology Board (NBTB) and
many other autonomous bodies representing the biotechnology sector, are working together
in order to project India as a global hub for biotech research and business excellence. Some
of the recent major initiatives are as follows:
• In the Union Budget 2017-18, the Department of Biotechnology (DBT) received Rs
2,222.11 crore (US$ 333.31 million), an increase of 22 per cent, to continue implementing
the department’s national biotech strategy and target increasing the turnover from the
sector to $100 billion by 2025 from $7 billion in 2016.
• The Telangana government also inked an MoU with PE firm Cerestra to explore a
'Life Sciences Infrastructure Fund' with a corpus of Rs 1,000 crore (US$ 150 million) to
create a sophisticated modular plug and play infrastructure for pharma, biotech and
medical devices industry.
Road Ahead
With the country offering numerous comparative advantages in terms of R&D facilities,
knowledge, skills, and cost effectiveness, the biotechnology industry in India has immense
potential to emerge as a global key player.
India constitutes around 8 per cent of the total global generics market, by volume, indicating
a huge untapped opportunity in the sector. Outsourcing to India is projected to spike up after
the discovery and manufacture of formulations. Hybrid seeds, including GM seeds, represent
new business opportunities in India based on yield improvement.
India currently has a marginal share in the global market for industrial enzymes. Hence,
there is an opportunity in focused R&D and knowledge-based innovation in the field of
industrial enzymes, which can innovatively replace polluting chemical processes into eco-
friendly processes that also deliver environmental sustainability. Another interesting field of
study is the area of bio-markers and companion diagnostics, which will enable to optimise
the benefits of biotech drugs.
Relation between pharmaceutical and biotechnological industry
Unlike in other countries, the difference between biotechnology and pharmaceuticals
remains fairly defined in India, with biotech a much smaller part of the economy. India
accounted for 2% of the $41 billion global biotech market and in 2003 was ranked 3rd in the
Asia-Pacific region and 13th in the world in number of biotech. In 2004-5, the Indian biotech
industry saw its revenues grow 37% to $1.1 billion. The Indian biotech market is dominated
by bio pharmaceuticals; 76% of 2004–5 revenues came from bio-pharmaceuticals, which
saw 30% growth last year. Of the revenues from bio-pharmaceuticals, vaccines led the way,
comprising 47% of sales. Biologics and large-molecule drugs tend to be more expensive than
small-molecule drugs, and India hopes to sweep the market in bio-generics and contract

25
manufacturing as drugs go off patent and Indian companies upgrade their manufacturing
capabilities.
Most companies in the biotech sector are extremely small, with only two firms breaking 100
million dollars in revenues. At last count there were 265 firms registered in India, over 92%
of which were incorporated in the last five years. The newness of the companies explains
the industry’s high consolidation in both physical and financial terms. Almost 30% of all
biotech are in or around Bangalore, and the top ten companies capture 47% of the market.
The top five companies were homegrown; Indian firms account for 72% of the bio-pharma
sector and 52% of the industry as a whole. The Association of Biotechnology-Led Enterprises
(ABLE) is aiming to grow the industry to $5 billion in revenues generated by 1 million
employees by 2009, and data from the Confederation of Indian Industry (CII) seem to
suggest that it is possible.
Bio-pharma accounts for majority market share
• The bio-pharmaceutical segment accounted for largest revenue share of 64 per cent
in India biotech industry, during FY16.
• In FY16, the bio-services and bio-agri segments accounted for 18.0 per cent and 14.0
per cent of the biotech industry, respectively.
• India is becoming a leading destination for clinical trials, contract research and
manufacturing activities which is leading to the growth of bio services sector.

26
Clinical research
Clinical research is a branch of healthcare science that determines the safety and
effectiveness (efficacy) of medications, devices, diagnostic products and treatment
regimens intended for human use. These may be used for prevention, treatment, diagnosis or
for relieving symptoms of a disease. Clinical research is different from clinical practice. In
clinical practice established treatments are used, while in clinical research evidence is
collected to establish a treatment.
The term "clinical research" refers to the entire bibliography of a drug/device/biologic, in fact
any test article from its inception in the lab to its introduction to the consumer market and
beyond. Once the promising candidate or the molecule is identified in the lab, it is subjected
to pre-clinical studies or animal studies where different aspects of the test article (including
its safety toxicity if applicable and efficacy, if possible at this early stage) are studied.
In the United States, when a test article is unapproved or not yet cleared by the Food and
Drug Administration (FDA), or when an approved or cleared test article is used in a way that
may significantly increase the risks (or decreases the acceptability of the risks), the data
obtained from the pre-clinical studies or other supporting evidence, case studies of off label
use, etc. are submitted in support of an Investigational New Drug (IND) application to the
FDA for review prior to conducting studies that involve even one human and a test article if
the results are intended to be submitted to or held for inspection by the FDA at any time in
the future (in the case of an already approved test article, if intended to submit or hold for
inspection by the FDA in support of a change in labeling or advertising). Where devices are
concerned the submission to the FDA would be for an Investigational Device
Exemption (IDE) application if the device is a significant risk device or is not in some way
exempt from prior submission to the FDA.
In addition, clinical research may require Institutional Review Board (IRB) or Research
Ethics Board (REB) and possibly other institutional committee reviews, Privacy Board,
Conflict of Interest Committee, Radiation Safety Committee, Radioactive Drug Research
Committee, etc. approval whether or not the research requires prior submission to the FDA.
Clinical research review criteria will depend on which federal regulations the research is
subject to (e.g., (Department of Health and Human Services (DHHS) if federally funded,
FDA as already discussed) and will depend on which regulations the institutions subscribe to,
in addition to any more stringent criteria added by the institution possibly in response to state
or local laws/policies or accreditation entity recommendations.

27
This additional layer of review (IRB/REB in particular) is critical to the protection of human
subjects especially when you consider that often research subject to the FDA regulation for
prior submission is allowed to proceed, by those same FDA regulations, 30 days after
submission to the FDA unless specifically notified by the FDA not to initiate the study.
Clinical research is often conducted at academic medical centers and affiliated research study
sites. These centers and sites provide the prestige of the academic institution as well as access
to larger metropolitan areas, providing a larger pool of medical participants. These academic
medical centers often have their internal Institutional Review Boards that oversee the ethical
conduct of medical research.
The clinical research ecosystem involves a complex network of sites, pharmaceutical
companies and academic research institutions. This has led to a growing field of technologies
used for managing the data and operational factors of clinical research. Clinical research
management is often aided by eClinical systems to help automate the management and
conducting of clinical trials.
Clinical trials involving new drugs are commonly classified into four phases. Each phase of
the drug approval process is treated as a separate clinical trial. The drug-development process
will normally proceed through all four phases over many years. If the drug successfully
passes through Phases I, II, and III, it will usually be approved by the national regulatory
authority for use in the general population. Phase IV are 'post-approval' studies.
OBJECTIVES OF THE STUDY
To understand the pattern of Recruiting employees by the companies which are in the
Healthcare sector comprising of the following segments which are taken into consideration
:
a) Pharmaceutical
b) Biotechnological
c) Clinical Research
INTERNSHIP ACTIVITIES
❖ In the beginning of the internship a task was given to prepare a CIT (Client
Information Template) report as a part of the internship . A CIT is basically a study noting
down various details of a Company such as its location , annual revenue , company history,
share price , market competitors , awards & recognition and SLOP analysis . Also , at the
same time suggesting HR Anexi for their next course of action and vice versa .
❖ Afterwards , it was asked to prepare a list of Health care companies including Bio-
pharma which are in and around Bengalure , with their address and contact details .

28
❖ The final part of the internship was to send Questionnaire to these listed companies in
order to gather information of their recruitment patterns and training procedures . This task is
taken as the main work that would provide relevant information which are beneficial for the
internship and vice versa .
RESEARCH METHODOLOGY
The study of conducting research is called research methodology.
Research: The word research is composed of two syllables‘re’ and ‘search’.
‘Re’ is the prefix meaning ‘again or over again or a new’and ‘Search’ is the latter meaning
‘to examine closely and carefully’ or ‘to test and try’. Together they form, a careful,
systematic and patient study and investigation in some field of knowledge undertaken to
establish policies or principles.
Types of research:
Research can be classified from the viewpoint-
• Application
• Objective
• Inquiry mode
Application research:
Pure research:
Gathering knowledge is termed as pure or basic research. Just to gather knowledge in order to
formulate or generalize theories.
E.g. research on mathematics.
Applied research:
To find an immediate solution for a pressing practical problem.
E.g. social, economical and political trends prevailing in a country.

29
Based on objective:
Descriptive Research:
• Survey or facts finding enquiries of different kinds. It describes the actual
prevailing state of affairs, existing at present.
• Otherwise known as ex post facts means existing position of facts /
issues.
• Here the variable influencing the research has no control or the researcher
has no control over the variables.
• E.g. frequency of shopping, customer preference etc.
Correlative research:
• Goes on to discover the existing relationship or interdependence between
two or more aspects / variables.
• Otherwise known as comparative study.
• Investigating association between variables.
• E.g. Sum of humor and job satisfaction.
Explanatory research:
• Attempts to clarify or explain why and how, any particular research
problem arises and can be solved.
Exploratory research:
• Study undertakes to explore a new area or an unknown destination.
Based on inquiry mode:
Quantitative research:
• Relates to aspects that can be quantified and expressed in terms of
quantity.
• Otherwise known as structured research

30
• In this type of research, the objective, design, sample and all the other
factors influencing the research is pre-determined.
• The research problem and its solution will be expressed in terms of
quantity and hence statistical and economic analysis is adapted in this
type of research.
Qualitative research:
• Otherwise known as unstructured research
• The aspects related to quality / kind or texture.
• E.g.: Behavior science
Research process:
• Formulating the research problem.
• Extensive literature survey.
• Development of working hypothesis.
• Preparing the research design.
• Determining sample design.
• Collecting the data.
• Execution of the project.
• Analysis of the data.
• Hypothesis - Testing
• Generalizations and interpretation
• Preparation of the report or the thesis
Importance of research:
• Doubt is better than over confidence for it leads to inquiry, inquiry leads to invention.
• Investigation of prevailing economic structure with the available facts.

31
• Analyze or diagnose the data
• Prediction for future developments.
• Research encourages scientific and inductive thinking.
Research design:
“A research design is the arrangement of conditions for collection and analysis of data in a
manner that aims to combine relevance to the research purpose with economy in procedure. “
The Research design highlights certain decision,
• The nature of study
• Purpose of study
• Location where the study would be conducted
• The nature of data required
• From where the data would be collected
• The techniques of data collection that would be used
• What time period the study would cover
• The type of sample design that would be used
• The method of data analysis that would be adapted
• The manner in which the report would be prepared.
SOURCES OF DATA
DATA COLLECTION TECHNIQUES:
There are two sources of data collection techniques. Primary and Secondary data collection
techniques, Primary data collection uses surveys, experiments or direct observations.
Secondary data collection may be conducted by collecting information from a diverse source
of documents or electronically stored information, census and market studies are examples of
a common sources of secondary data. This is also referred to as "data mining."
PRIMARY DATA:
Primary data means original data that has been collected specially for the purpose in mind. It
means someone collected the data from the original source first hand. Data collected this way
is called primary data.
Primary data has not been published yet and is more reliable, authentic and objective.
Primary data has not been changed or altered by human beings; therefore its validity is
greater than secondary data.

32
Survey
Survey is most commonly used method in social sciences, management,
marketing and psychology to some extent. Surveys can be conducted in
different methods.
Questionnaire
Questionnaire is the most commonly used method in survey.
Questionnaires are a list of questions either an open-ended or close -ended for
which the respondent give answers. Questionnaire can be conducted via
telephone, mail, live in a public area, or in an institute, through electronic mail
or through fax and other methods.
Interview
Interview is a face-to-face conversation with the respondent. It is slow,
expensive, and they take people away from their regular jobs, but they allow in-
depth questioning and follow-up questions.
Observations
Observations can be done while letting the observing person know that he is being
observed or without letting him know. Observations can also be made in natural settings as
well as in artificially created environment.
Under this project the form of survey used is questionnaire. We prepared a set of questions
related to the appropriate department which was Recruitment and went to different people in
order to gather data and ask related questions.
ADVANTAGES OF PRIMARY DATA:
• Data interpretation is better.
• Targeted Issues are addressed.
• Efficient Spending for Information.
• Decency of Data.
• Addresses Specific Research Issues.
• Greater Control.
• Proprietary Issues.

33
DISADVANTAGES OF PRIMARY RESEARCH:
• High Cost
• Time Consuming
• Inaccurate Feed-backs
• More number of resources is required
SECONDARY DATA:
Secondary data is the data that has been already collected by and readily available from other
sources. When we use Statistical Method with Primary Data from another purpose for our
purpose we refer to it as Secondary Data. It means that one purpose's Primary Data is another
purpose's Secondary Data. So that secondary data is data that is being reused. Such data are
more quickly obtainable than the primary data.
These secondary data may be obtained from many sources, including literature,
industry surveys, compilations from computerized databases and information systems, and
computerized or mathematical models of environmental processes.
Published Electronic Sources
As internet is becoming more advance, fast and reachable to the masses; it has been
seen that much information that is not available in printed form is available on internet. In the
past the credibility of internet was questionable but today it is not. The reason is that in the
past journals and books were seldom published on internet but today almost every journal and
book is available online. Some are free and for others you have to pay the price.
E-journals: e-journals are more commonly available than printed journals.
Latest journals are difficult to retrieve without subscription but if your university has an e-
library you can view any journal, print it and those that are not available you can make an
order for them.
General Websites; Generally websites do not contain very reliable information so their
content should be checked for the reliability before quoting from them.
Weblogs: Weblogs are also becoming common. They are actually diaries written by
different people. These diaries are as reliable to use as personal written diaries.

34
ADVANTAGES OF SECONDARY DATA:
• Inexpensive
• Easily accessible
• Immediately available
• Will provide essential background and help to clarify or refine
research problem – essential for literature review
• Secondary data sources will provide research method alternatives.
• Will also alert the researcher to any potential difficulties.
DISADVANTAGES OF SECONDARY DATA:
• Expensive
• Not immediately available – takes time to define problem, sampling
frame, method and analysis.
• Not as readily accessible
• Incomplete Information.

37
◆ In this study employee questionnaire is one of the major instruments used in data
collection. It is employed to collect information from the perspective of the managers
regarding issues undertaken.
◆ A questionnaire is a research instrument consisting of a series of questions (or other
types of prompts) for the purpose of gathering information from respondents.
◆ Questionnaires have advantages over some other types of surveys in that they are cheap,
do not require as much effort from the questioner as verbal or telephone surveys, and
often have standardized answers that make it simple to compile data.
◆ Usually, a questionnaire consists of a number of questions that the respondent has to
answer in a set format. A distinction is made between open-ended and closed-ended
questions. An open-ended question asks the respondent to formulate his own answer,
whereas a closed-ended question has the respondent pick an answer from a given number
of options. The response options for a closed-ended question should be exhaustive and
mutually exclusive.
ANALYSIS AND INTERPRETATION
Once the required data has been collected, the next step is to analyse and discuss the data
obtained in order to arrive at the answers of some research questions, which are addressed on
the basis of the general aims of the investigations. Data analysis refers to shifting, organising,
summarizing and synthesizing the data so as to arrive at the results and conclusions of the
research. Thus, data analysis becomes the product of all considerations involved in the design
and planning of the research.
1. What is the % of recruitment through following methods your organization ?

38
Company Names Employee Reference Identified by recruitment team
Identified by Lin
Accelyrs Inc 14 25 10
Allergen Pvt Ltd 17 25 20
Amadeus India 13 24 17
Anthem Biosciences Pvt Ltd 12 24 26
Biocon Pvt Ltd 10 30 20
Biovet Pvt Ltd 15 20 10
Biozeen Pvt Ltd 15 25 15
Cambium Biotech 16 24 14
Cipla 14 24 17
Farmacia 15 20 10
Herbal Life 12 26 13
Indegene 10 28 20
Jubilant Biosys Ltd 11 25 24
Kayapees Biotech Pvt Ltd 20 15 20
Kemwell 15 20 10
Medreich Ltd 20 15 20
Novozymes 16 25 15
Omega Healthcare 15 20 10
Orgio Pharmaceuticals 10 40 20

39
2. What are the percentages of recruitment of fresh candidates in your company from the
following sources?
A) For B.Pharma graduates
14 17 13 12 10
15 15 16 14 15 12 10 11
20
15
20 16 15
10
15 14
25
25
24 24 30 20
25 24 24 20 26 28 25
15
20
15 25
20 40 25 25
10
20
17
26 20
10
15 14 17
10
13
20 24
20
10
20
15
10
20
15
10
26
23
20
14
25
20
25 26 25
20
25
25 25
15
20
15
24
20
22
25
26
15
10
16 16
10
20
15 12 15
20
14
10 10
20
20
20
15
20
15 15
15
10
5
10 8 5
15
5 8 5
15
10
5 5
10
15
10
5
15
5 5
10
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Chart Title
Series1 Series2 Series3 Series4 Series5 Series6
Philips Healthcare 15 25 15
Quintiles 14 25 10

40
Company Names
Campus recruitment
Employee referrals Advertised Search Rec
Accelyrs Inc 15 13 11 10
Allergen Pvt Ltd 13 10 12 13
Amadeus India 12 13 13 11
Anthem Biosciences Pvt Ltd 14 13 10 13
Biocon Pvt Ltd 14 13 11 11
Biovet Pvt Ltd 13 13 11 12
Biozeen Pvt Ltd 12 14 12 13
Cambium Biotech 10 13 11 15
Cipla 11 13 11 11
Farmacia 10 13 15 14
Herbal Life 8 14 14 13
Indegene 15 13 11 10
Jubilant Biosys Ltd 14 10 12 12
Kayapees Biotech Pvt Ltd 9 11 14 16
Kemwell 10 14 12 16
Medreich Ltd 9 11 14 13
Novozymes 13 15 11 16
Omega Healthcare 11 13 16 12
Orgio Pharmaceuticals 14 10 13 15
Philips Healthcare 15 13 11 10
Quintiles 1410 12 13

41
B) M.Pharma graduates
Company Names
Campus recruitment
15 13 12 14 14 13 12 10 11 10 8
15 14
9 10 9 13 11 14 15 14
13
10 13 13 13 13 14
13 13 13 14
13
10
11
14
11
15
13 10
13
10
11
12
13 10 11 11 12
11 11 15 14
11
12
14
12
14
11 16 13
11
12
10
13 11 13 11 12 13
15 11
14
13 10 12 16 16
13
16 12 15 10 13
12 12 13 12 13 12
13
12
13
16
15 12 15 13
15
15
15
16
10 12 15
14 15 14 13 13 14
14
13 15
13
14
14 13 15 9
14
13 13
14 14 12
12 13 11 12 14 13
12
14 12
11
12
12 14 12 14 13
10 11
10 12 14
13 12 13 13 11 12 10 12 14
8 10 13 10 10 10 11 7 8
14 13 10
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Chart Title
Campus recruitment Employee referrals
Advertised Search Recruitment Agencies
Job Portal Candidates upload their resume to your website
Walk in interviews Social media Search

42
Cipla 11 13 11 11
Kemwell 10 14 12 16
Quintiles 1410 12 13

43
C) Management Graduates
Company Names
Campus recruitment
12 9 13 11 14 15 12 12 11 10 8 15 14 9 10 9 13 11 14 15 14
14 15 12 13 13 13 14 14 13 13 14
13 10
11 14 11
15 13 10 13 10
10 12 13 10 11 11 12 10 11 15 14
11 12 14 12 14
11 16 13 11 12
13 13 11 13 11 12 13 13 11
14 13 10 12 16 16 13
16 12 15 10 13
12 12 13 12 13 12 13 12 13
16 15 12 15 13 15
15
15 16 10 12 15
14 14 14 14 13 14 14 14 15
13 14 14 13 15 9 14
13 13
14 14 12
12 13 11 12 14 13 12 12 12
11 12 12 14 12 14 13
10 11
10 12 14
13 12 13 15 11 10 10 13 14 8 10 13 10 10 10 11 7 8 14 13 10
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Chart Title

44
Cipla 11 13 11 11
Kemwell 10 14 12 16
Quintiles 12 14 10 13
12 9 13 11 14 15 12 12 11 10 8 15 14 9 10 9 13 10 9 15 12
14 15 12 13 13 13 14 14 13 13 14
13 10 11 14 11
15 14 11
13 14
10 12 13 10 11 11 12 10 11 15 14 11 12 14 12 14
11 12 14
11 10
13 13 11 13 11 12 13 13 11 14 13 10 12 16 16 13
16 16 13 10 13
12 12 13 12 13 12 13 12 13
16 15 12 15 13 15
15
15 15
15 12 12
14 14 14 14 13 14 14 14 15
13 14 14 13 15 9 14
13
9 14 14 14
12 13 11 12 14 13 12 12 12
11 12 12 14 12 14 13
10
14 13 12 12
13 12 13 15 11 10 10 13 14 8 10 13 10 10 10 11 7 10 11 13 13
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Chart Title

45
CHAPTER-IV
ASSESSMENT OF THE INTERNSHIP
ASSESSMENT OF THE INTERNSHIP
Skills gained from the internship :
✓ As an intern it was my first experience to be exposed to a corporate
work culture and get along with it and I was able to learn the various
techniques and approaches in order to collect data from a company as a
research work purpose .
✓ Strictly speaking , I was able to develop my level of patience at the same
time the convincing ability to gather information despite when at times I was
turned down .
✓ Time management was one of the aspects that was one of the crucial
skill that I had learned throughout the internship .
✓ I believe the soft-skills that are required for getting employed was
identified and I developed them .
Responsibilities undertaken during the internship

46
✓ The preparation for CITs for different companies as a part of Internship.
✓ Sending Questionnaires to gather information and details about their style
of recruitment and selection for employment within the company.
Correlation of Internship activities with Classroom knowledge
✓ The subjects like Organization Behaviour in 1st
semester and Human
Resource Management in 2nd
Semester was able to provide various
knowledge that are required to get along into corporate culture to produce
outcome effectively .
✓ Excel was used for various purposes in order to gather and organize the
datas required for the internship.

48
Conclusion
◼ In this research work it was found that the various companies have a
different pattern of recruitment and selecting candidates for
employability in their organization .
◼ As per the data that was collected it was understood that the
Healthcare companies take up more B.Pharma and M.Pharma
graduates as compared to Management graduates .
◼ These healthcare companies look upto skilled employees for
effective productivity and quality of work .
Limitations of the Study:
The limitations of my project include:

49
1) Limitation of time is a major constraint in making a complete study, due to time
limitation. The duration is only forty-five days. It is too limited to cover all the area.
2) Lack of comprehension of the respondents is the major problem.
3) Confidentiality of data cannot be revealed, which is another important barrier.
4) Research mainly restricted to the internet and limited access of company data.
APPENDIX
BIBLIOGRAPHY
https://en.wikipedia.org/wiki/Healthcare_industry
https://en.wikipedia.org/wiki/Pharmaceutical_industry
https://www.ibef.org/industry/healthcare-india.aspx
http://www.hranexi.com/
in.linkedin.com

50
QUESTIONNAIRE
1. What is the % of recruitment through following methods your organization ?
2. What are the percentages of recruitment of fresh candidates in your company from the
following sources?
Employee
Reference
Identified
by
recruitment
team
Identified
by Line
managers
Recruitment
consultants
Team
movement
(with a new
senior just
joined in
your
company)
Job
rotations,
Promotions
etc.
No.
%

51
3. How do you publish the vacancies ?
1. Method % of
B.Pharma
graduates
% of
M.Pharma
graduates
% of
Management
Graduates
% of other
qualifications
Total
a. Campus
recruitment
b. Employee
referrals
c. Advertised
search
d. Recruitment
agencies
e. e.Job portals
f. Candidates
upload their
resume to
your
website
g. Walk in
interviews
h. Social Media
Search
i. Others-
please
specify
Entry
Level
Individual
Contributors
First Time
Managers
Middle
Managers
Top
Managers
a. Campus recruitment
b. Employee referrals
c. Newspaper
Advertisements
d. Recruitment agencies
e. e.Job portals
f. Your Website
g. Walk in interviews
h. Social Media
i. HR Forums
j. Others- please specify

52
4. Do you send your employees into any training programme so as to
increase their effectiveness in the organization ? If yes , then how often ?
Once in every
year
Once in every 6
months
Once in every
3 months
Once in a
month
Once in a
week
5. Do you make survey to make a note on the current wants and needs as
well keeping a record of the feedbacks from the existing customers ?
⚫ Most of the times
⚫ Regularly
⚫ Highly unlikely

Summer internship - 2017 HR Anexi

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Summer internship - 2017 HR Anexi

Similar to Summer internship - 2017 HR Anexi (20)

Summer internship - 2017 HR Anexi